Concepedia

Han Min

HM

Statistics

Publications

8

Citations

192

H-Index

8

Active since

2014

Affiliations

Nanjing Medical University(Current)

Suzhou Municipal Hospital

Soochow University

Nantong University

University of Oklahoma Health Sciences Center

Han Min is an author at Nanjing Medical University specializing in autophagy, cancer research, and cell death.

ORCID

Top concepts

Publications per year

2014–2021

8

Publications

8

Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells

Zhijun Huang, Shusheng Wang, Han Min et al. · Tumor Biology · 2016 · 59 citations

Bortezomib induces protective autophagy through AMP-activated protein kinase activation in cultured pancreatic and colorectal cancer cells

Han Min, Min Xu, Zhirong Chen et al. · Cancer Chemotherapy and Pharmacology · 2014 · 55 citations

, , +10

Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation

Yuandong Cao, Aidi Gao, Xiaoqing Li et al. · Cancer Medicine · 2021 · 17 citations · Full text

LncRNA HEIH promotes cell proliferation, migration and invasion by suppressing miR-214-3p in gastric carcinoma

Lei Jiang, Luyao Zhang, Qian Chen et al. · The Journal of Biochemistry · 2020 · 14 citations

LYTAK1, a novel TAK1 inhibitor, suppresses KRAS mutant colorectal cancer cell growth in vitro and in vivo

Jundong Zhou, Bing Zheng, Jiansong Ji et al. · Tumor Biology · 2014 · 13 citations

1–5 of 8